新闻Cormorant Asset Management invests into Aardvark Therapeutics, Inc. $85M.Aardvark Therapeutics has raised an $85 million oversubscribed Series C financing led by Decheng Capital, with participation from Cormorant Asset Management, Surveyor Capital, SymBiosis, Tetragon Financial Group, Walleye Capital, Laurion Capital Management, LG Technology Ventures, Cantor Ventures, Silver Arc Private Capital, The Prader-Willi Syndrome Association - USA, and existing investors, including Vickers Venture Partners and the Foundation for Prader-Willi Research.
新闻Cormorant Asset Management invests into Neurona Therapeutics, Inc. $120M.Neurona Therapeutics, a biotherapeutics company focused on creating regenerative cell therapy for the treatment of neurological disorders, has secured $120 million in a funding round co-led by Viking Global Investors and Cormorant Asset Management, with participation from new and existing investors SymBiosis, Alexandria Venture Investments, Berkeley Frontier Fund and others.
新闻Cormorant Asset Management invested into BiVACOR Inc. $18M on Mar 1st '23.In March 2023, Bivacor received $18 million in funding led by Boston-based Cormorant Asset Management and Australian venture capital firm OneVentures, through the OneVentures Healthcare Fund III.
